Life Scientist > Biotechnology

HealthLinx scores high with OvPlex

08 December, 2008 by Kate McDonald

HealthLinx reports 98 per cent efficiency with ovarian cancer diagnostic


Phosphagenics reports pain relief

08 December, 2008 by Kate McDonald

Phosphagenics reports early results from lidocaine topical delivery trial


Two more for AtCor

08 December, 2008 by Kate McDonald

Drug trial contracts bring total worth to US $5.7m in past six months


Crop scientist one of Nature’s finest

04 December, 2008 by Kate McDonald

Australian named as 'researcher who could change the world'


Metabolic-PolyNovo deal dies

02 December, 2008 by Kate McDonald

Metabolic shareholders put the kybosh on acquisition of PolyNovo


Novogen subsidiary files IND

02 December, 2008 by Kate McDonald

Marshall Edwards files IND for chemo-sensitising agent


Prana looks at Huntington’s

02 December, 2008 by Kate McDonald

Prana to investigate lead candidate in Huntington’s disease


Biotech in brief

02 December, 2008 by Kate McDonald

BioDiem, Anadis


Toothy heroes in a half-shell

27 November, 2008 by Kate McDonald

Earliest known turtle fossils shed light on shell development


Arana's pilot for arthritis

26 November, 2008 by Kate McDonald

Arana to run dosage trial for rheumatoid arthritis application


Avexa completes “jewel” recruitment

26 November, 2008 by Kate McDonald

Avexa concludes recruitment for Phase III, reducing cash burn


Uncovering the parasite metabolome

24 November, 2008 by Kate McDonald

How metabolomics took on scientist from studying Antarctic microbiology to tropical parasitology.


Drastic cost-cutting at Benitec

20 November, 2008 by Kate McDonald

Benitec retrenches staff to reduce cash burn


Xenome gets acute

19 November, 2008 by Kate McDonald

Xenome licenses IP for acute pancreatitis peptides


Cancer drugs reverse diabetes in mice

18 November, 2008 by Kate McDonald

Tyrosine kinase inhibitors reverse type 1 diabetes in mice


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd